Medical Innovation Exchange

AdvaMed

EPA Announces Proposed Rules To Reduce Ethylene Oxide Exposure

EPA Announces Proposed Rules To Reduce Ethylene Oxide Exposure     On April 11, the Environmental Protection Agency (EPA) proposed new health protections to reduce exposure to Ethylene Oxide (EtO). These include a proposed rule regulating ethylene oxide (EtO) sterilizers of medical technology and other commercial uses through the National Emission Standards for Hazardous Air Pollutants …

EPA Announces Proposed Rules To Reduce Ethylene Oxide Exposure Read More »

Qiagen CEO Named Chair of AdvaMedDx Board of Directors

Qiagen CEO Named Chair of AdvaMedDx Board of Directors     Thierry Bernard, CEO of Qiagen has been elected Chair of the AdvaMedDx Board of Directors. AdvaMedDx is a division of AdvaMed representing more than 75 manufacturers of in vitro diagnostic (IVD) tests and technologies in the U.S. and abroad. Bernard joined Qiagen in 2015 and …

Qiagen CEO Named Chair of AdvaMedDx Board of Directors Read More »